Camber has launched 36 new generic products in 2024, expanding choices for patients and healthcare providers. With even more product launches planned for 2025, Camber remains at the forefront of delivering affordable solutions to support healthier communities nationwide.
- Avanafil Tablets
- Ketorolac Injection SDV
- Decitabine Intravenous Solution
- Capecitabine Tablets
- Lisdexamfetamine Capsules
- Lisdexamfetamine Chewable Tablets
- Lidocaine HCL Injection MDV
- Lidocaine HCL Injection SDV
- Dabigatran 110mg Capsules
- Diatrizoate Meglumine & Diatrizoate Sodium Solution
- Ivabradine Tablets
- Eszopiclone Tablets
- Ezetimibe Tablets
- Theophylline ER Tablets
- Bortezomib Injection
- Gabapentin Oral Solution
- Pantoprazole PFOS
- Sirolimus Oral Solution
- Divalproex Sodium ER Tablets
- Pitavastatin Tablets
- Mesalamine DR Tablets
- Rufinamide Oral Suspension
- Levonorgestrel-Ethinyl Estradiol
- Allopurinol Tablets
- Aripiprazole Oral Solution
- Gabapentin Tablets
- Quetiapine Fumarate Tablets
- Fesoterodine ER Tablets
- Icosapent Ethyl Capsules
- Atorvastatin Tablets
- Varenicline Tablets
- Oxcarbazepine Oral Suspension
- Paliperidone ER Tablets
- Erlotinib Tablets
- Dicyclomine HCl Capsules
- Dicyclomine HCl Tablets